Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “YUTIQ”

50 trials

Showing 20 of 50 results

Post-approval studies (Phase 4)Study completedNCT02359526
What this trial is testing

A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients

Who this might be right for
Diabetic Macular Edema
Association for Innovation and Biomedical Research on Light and Image 12
Large-scale testing (Phase 3)WithdrawnNCT03784443
What this trial is testing

Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

Who this might be right for
Diabetic Macular EdemaDiabetes
Imperial College London
Large-scale testing (Phase 3)Study completedNCT00344968
What this trial is testing

Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Alimera Sciences 956
Large-scale testing (Phase 3)Study completedNCT01694186
What this trial is testing

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert

Who this might be right for
Non-Infectious Uveitis
EyePoint Pharmaceuticals, Inc. 129
Not applicableStudy completedNCT00570830
What this trial is testing

Retisert and Cataract Surgery in Patients With Severe Uveitis

Who this might be right for
Intermediate UveitisPosterior Uveitis
Duke University 21
Testing effectiveness (Phase 2)UnknownNCT00032396
What this trial is testing

Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Control Delivery Systems
Not applicableLooking for participantsNCT05592717
What this trial is testing

YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis

Who this might be right for
UveitisYUTIQ
Tianjin Medical University 15
Post-approval studies (Phase 4)Active Not RecruitingNCT05322070
What this trial is testing

Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis

Who this might be right for
Uveitis, Posterior
Alimera Sciences 125
Large-scale testing (Phase 3)Ended earlyNCT00456482
What this trial is testing

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant

Who this might be right for
Non-infectious Uveitis
Bausch & Lomb Incorporated 239
Post-approval studies (Phase 4)Study completedNCT02472366
What this trial is testing

A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy

Who this might be right for
Chronic Diabetic Macular Edema
Alimera Sciences 16
Large-scale testing (Phase 3)Study completedNCT00468871
What this trial is testing

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy

Who this might be right for
Non-infectious Uveitis
Bausch & Lomb Incorporated 140
Large-scale testing (Phase 3)Study completedNCT01867164
What this trial is testing

Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis

Who this might be right for
VaginitisInfectious Vaginosis
Janssen-Cilag, S.A. 160
Testing effectiveness (Phase 2)Ended earlyNCT00695318
What this trial is testing

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
Alimera Sciences 17
Post-approval studies (Phase 4)WithdrawnNCT02902744
What this trial is testing

Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study

Who this might be right for
Diabetic Macular Edema
Johns Hopkins University
Not applicableStudy completedNCT00952614
What this trial is testing

A Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
Glenn Jaffe 29
Early research (Phase 1)Study completedNCT00008515
What this trial is testing

Fluocinolone Implant to Treat Macular Degeneration

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
National Eye Institute (NEI) 16
Post-approval studies (Phase 4)Looking for participantsNCT06539481
What this trial is testing

Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

Who this might be right for
Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Alimera Sciences 25
Testing effectiveness (Phase 2)Study completedNCT00576459
What this trial is testing

Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Bausch & Lomb Incorporated 40
Large-scale testing (Phase 3)UnknownNCT04636957
What this trial is testing

A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE)

Who this might be right for
Acute Otitis Externa
Lee's Pharmaceutical Limited 600
Post-approval studies (Phase 4)Study completedNCT00472966
What this trial is testing

Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma

Who this might be right for
Melasma
Galderma R&D 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation